STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Clinical trials for STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Punch attack on lung cancer: zap then cut
Disease control OngoingThis small, early-stage study is testing the safety of a two-step treatment for early-stage non-small cell lung cancer. First, patients receive a single, highly focused dose of radiation to their tumor. Then, about a month later, they have surgery to remove it. The goal is to see…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Phase: EARLY_PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Targeted drug trial aims to stop lung Cancer's comeback
Disease control OngoingThis study is testing if a drug called crizotinib can help prevent early-stage lung cancer from coming back after surgery. It is for patients whose cancer has a specific genetic change called ALK-positive. After surgery, participants are randomly assigned to either take the drug …
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists aim to zap lung tumors more precisely, spare healthy tissue
Disease control OngoingThis study is testing two advanced, precise ways to deliver radiation therapy alongside standard chemotherapy for people with stage II or III non-small cell lung cancer. The goal is to see if these methods can safely deliver a stronger dose of radiation directly to the tumor whil…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC